Big Pharma Split Corp (PRM.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Cash Flows From Operating Activities | ||||
| Other Working Capital | -32 | -3 | -54 | 54 |
| Other Operating Activity | 4,380 | 8,682 | 1,325 | -31,008 |
| Operating Cash Flow | $4,348 | $8,679 | $1,271 | $-30,954 |
| Cash Flows From Investing Activities | ||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | N/A | N/A | 0 | 20,400 |
| Common Stock Repurchased | -1,687 | -3,658 | -265 | N/A |
| Dividend Paid | -1,731 | -2,084 | -2,253 | N/A |
| Other Financing Activity | -1,234 | -2,827 | -191 | 12,335 |
| Financing Cash Flow | $-4,652 | $-8,569 | $-2,710 | $32,735 |
| Exchange Rate Effect | -1 | 9 | 10 | 64 |
| Beginning Cash Position | 536 | 417 | 1,846 | 0 |
| End Cash Position | 231 | 536 | 417 | 1,846 |
| Net Cash Flow | $-304 | $110 | $-1,439 | $1,781 |
| Free Cash Flow | ||||
| Operating Cash Flow | 4,348 | 8,679 | 1,271 | -30,954 |
| Free Cash Flow | 4,348 | 8,679 | 1,271 | -30,954 |